No relevance whatsoever to the last two years of media on this planet.
Innate Immune Suppression by SARS-CoV-2 mRNA Vaccinations
The mRNA SARS-CoV-2 vaccines were brought to market in response to the widely perceived public health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious disease had no precedent, but desperate times seemed to call for desperate measures. The mRNA vaccines utilize genetically modified mRNA encoding spike proteins. These alterations hide the mRNA from cellular defenses, promote a longer biological half-life for the proteins, and provoke higher overall spike protein production. However, both experimental and observational evidence reveals a very different immune response to the vaccines compared to the response to infection with SARS-CoV-2. As we will show, the genetic modifications introduced by the vaccine are likely the source of these differential responses. In this paper, we present the evidence that vaccination, unlike natural infection, induces a profound impairment in type I interferon signaling, which has diverse adverse consequences to human health. We explain the mechanism by which immune cells release into the circulation large quantities of exosomes containing spike protein along with critical microRNAs that induce a signaling response in recipient cells at distant sites. We also identify potential profound disturbances in regulatory control of protein synthesis and cancer surveillance. These disturbances are shown to have a potentially direct causal link to neurodegenerative disease, myocarditis, immune thrombocytopenia, Bell’s palsy, liver disease, impaired adaptive immunity, increased tumorigenesis, and DNA damage. We show evidence from adverse event reports in the VAERS database supporting our hypothesis. We believe a comprehensive risk/benefit assessment of the mRNA vaccines excludes them as positive contributors to public health, even in the context of the Covid-19 pandemic.
Who Is Liable In The Covid Case?
UK Lawyer Anna de Buisseret explains.
Actual Stats Do Not Support The Fear Mongering
Great presentation of actual UK data completely disproving the entire necessity for pandemic responses.
The Shots Not Preventing Deaths
Message for 2022: Three things to remember at this critical time from RFK, Jr.
Public Announcement – UK Police Investigation
46 Gardening Hacks
He also mentions Eliott Coleman as one of the best garden authors.
Fibre
Eat to feed your gut microbes who like fibre.
Diversity of gut microbes is a measure of health.
Diversity on the plate leads to diversity (therefore health) of the gut!
Diversity of plants in the diet is the single most important determinant of gut health.
Lack of fibre is our most prevalent and important nutritional deficiency.
The minimal recommended dose of fibre is 25 grams for women and 38 grams for men. That’s not optimal, that’s minimum!
Actual average consumption is 15-18 grams. 95% of Americans do not even get the minimal recommended amount of fibre.
His acronym to remember which foods to consume is FGOALS
Fruits and Fermented
Greens and Whole Grains
Omega-3 from Chia, Flax and Hemp and Walnuts
Aromatics – Garlic, Onions Shallots
Legumes – Lentils, Peas and Beans
Sea vegetables, ’shrooms, sulforaphane (cruciferous broccoli sprouts, Brussels Sprouts and cauliflower)
Dr Will Bulsiewicz Gastrointestinal Doctor
(Interesting side note, 60% by weight of your stools is not food waste, it is gut microbes!)
Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment
“These drugs have been suppressed… for reasons that have nothing to do with the science and the medicine.”
In this episode, we sit down with Dr. Harvey Risch, a professor of epidemiology at the Yale School of Public Health and Yale School of Medicine. He says therapeutics, including hydroxychloroquine and ivermectin, can be highly effective against COVID when they are deployed early on and in combination with different medications.
In the interview, Dr. Risch criticizes the U.S. Food and Drug Administration (FDA) for warning against hydroxychloroquine and chloroquine use to treat COVID-19 and revoking the emergency use authorization (EUA) for hydroxychloroquine and chloroquine.
The FDA told The Epoch Times in an email that the FDA made this decision after testing the efficacy of hydroxychloroquine for treating COVID-19, including in patients in an outpatient setting.
But Dr. Harvey Risch argues that outpatient reports are exceedingly few because the medication is extremely safe and the emergency use authorization in March 2020 blocked outpatient use, and he believes the FDA has conflated heart rhythm problems from severe COVID infection with adverse effects from hydroxychloroquine use in hospitalized patients.